Wieshofer, Marni — Insider Profile

Insider Profile

Wieshofer, Marni

🔒 Follow — get an alert on any new filing

$OGI

Companies Filed At

Open-Market Buys (2yr)

$8K

Buy Value (2yr, open-market)

Oct 28, 2025

Most Recent Trade

Credibility
Score

57%

Hit Rate

+29.1%

Avg 90d Return

+27.8%

Median 90d Return

Evaluated Trades

+97.6%

Best Trade

-21.1%

Worst Trade

Hit rate and returns are based on 7 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. Limited signal — either below-average timing or insufficient trade history.

Cross-Company Track Record

THIN HISTORY

100%

Hit Rate · 90d

+24.9%

Median Alpha · 90d

Closed Buys Evaluated

100%

Beat XIU

All-insider base rate: 59% hit rate · +1.3% mean alpha (n=11504)

size concentrated

Entry: closing price on SEDI filing date (point-in-time). Exit: 90 calendar days later. Alpha vs XIU.TO (iShares TSX 60). Closed trades only. Not investment advice.

Research 1 closed buys with individual return outcomes available on the Research plan.

Date	Company	Role	Nature	Dir.	Shares	Price	Value	Score
Oct 28, 2025	$OGI Organigram Holdings	—	Comp. Grant	Buy	45,081	—	—	70
Apr 02, 2025	$OGI Organigram Holdings	—	Open Market	Buy	7,500	$1.04	$8K	70
Oct 28, 2024	$OGI Organigram Holdings	—	Comp. Grant	Buy	37,795	$2.54	$96K	70
Dec 21, 2023	$OGI Organigram Holdings	—	Comp. Grant	Buy	59,428	$1.75	$104K	70
Jul 05, 2023	$OGI Organigram Holdings	—	Corp. Event	Sell	7,500	—	—	70
Jul 05, 2023	$OGI Organigram Holdings	—	Corp. Event	Sell	92,102	—	—	70
Jul 05, 2023	$OGI Organigram Holdings	—	Corp. Event	Sell	60,000	—	—	70
Sep 29, 2022	$OGI Organigram Holdings	—	Comp. Grant	Buy	78,048	$1.23	$96K	70
Jan 25, 2021	$OGI Organigram Holdings	—	Comp. Grant	Buy	17,514	$2.25	$39K	70
Jan 25, 2021	$OGI Organigram Holdings	—	Comp. Grant	Buy	80,000	$2.25	$180K	70

Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.